Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Background Group A Streptococcus (GAS) M protein is an important virulence factor and potential vaccine antigen, and constitutes the basis for strain typing (emm-typing). Although >200 emm-types are characterized, structural data were obtained from only a limited number of emm-types. were aim to evaluate the sequence diversity of near-full-length M proteins from worldwide sources and analyse their structure, sequence conservation and classification. Methods GAS isolates recovered from throughout the world during the last two decades underwent emm-typing and complete emm gene sequencing. Predicted amino acid sequence analyses, secondary structure predictions and vaccine epitope mapping were performed using MUSCLE and Geneious software. Results 1086 isolates from 31 countries were analysed, representing 175 emm-types. emm-type is predictive of the whole protein structure, independent of geographic origin or clinical association. Findings of an emm-type paired with multiple, highly divergent central regions were not observed. M protein sequence length, the presence or absence of sequence repeats, and predicted secondary structure was assessed in the context of the latest vaccine developments. Conclusions Based on these global data, the M6 protein model is updated to a three representative M protein (M5, M80, M77) model, to aid in epidemiological analysis, vaccine development and M protein-related pathogenesis studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of group A streptococcal diseases
Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70267-x · Cited by 2,998 · cited 1×
“Amongst bacterial pathogens afflicting humans, group A streptococcus (GAS) is a leading cause of global morbidity and mortality [1].”
BackgroundSelf-citationPathogenesis of Group A Streptococcal Infections
Cunningham, M. W. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.470 · Cited by 2,261
Streptococcal M protein: molecular design and biological behavior
Fischetti, V. A. (1989) · Clinical Microbiology Reviews · doi:10.1128/cmr.2.3.285 · Cited by 827 · cited 2×
“Much of our understanding of M protein structure and function is based on early work on the M6 protein, an emm pattern A–C type [7].”
BackgroundMethodSortases and the Art of Anchoring Proteins to the Envelopes of Gram-Positive Bacteria
Marraffini, L. A., DeDent, A. C., & Schneewind, O. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.70.1.192-221.2006 · Cited by 686 · cited 1×
“The M protein is a fibrillar coiled-coil dimer that extends from the bacterial cell wall, and is considered an archetypal Gram-positive surface protein [3].”
BackgroundIntragenic tandem repeats generate functional variability
Verstrepen, K. J., Jansen, A., Lewitter, F., & Fink, G. R. (2005) · Nature Genetics · doi:10.1038/ng1618 · Cited by 616 · cited 1×
“In fungi, size variation generated by intragenic tandem repeats within surface protein genes allows for rapid adaptation to the environment and/or evasion of the host immune system [27].”
BackgroundSteer, A. C., Law, I., Matatolu, L., Beall, B. W., & Carapetis, J. R. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70178-1 · Cited by 537 · cited 4×
“Based on the data obtained in this study, and on information from published literature [4,9,10,13], we propose a new structural model with three representative M proteins (Fig.”
BackgroundMethodInfluentialSelf-citationMolecular basis of group A streptococcal virulence
Bisno, A., Brito, M., & Collins, C. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00576-0 · Cited by 510 · cited 1×
“M proteins are multifunctional, having roles in preventing phagocytosis, mediating adherence to host cells and intracellular invasion, often through binding to human host products such as fibrinogen, factor H, albumin, IgA and IgG, plasminogen and others [26].”
BackgroundDale, J. B., Penfound, T. A., Chiang, E. Y., & Walton, W. J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.005 · Cited by 258 · cited 3×
“A new multivalent antigen containing amino-terminal fragments from 30 M proteins showed unexpected in vitro cross-protection against isolates expressing M proteins not included in the immunizing antigen [15].”
BackgroundThe streptococcal M protein: a highly versatile molecule
Smeesters, P. R., McMillan, D. J., & Sriprakash, K. S. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.02.007 · Cited by 220 · cited 5×
“The multifunctional nature of this protein is also evident from its interactions with numerous host proteins [4], occurring along the entire length of the surface-exposed portion of M protein.”
BackgroundMethodInfluentialSelf-citationT-REKS: identification of Tandem REpeats in sequences with a K-meanS based algorithm
Jorda, J., & Kajava, A. V. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp482 · Cited by 185
Streptococcal skin infection and rheumatic heart disease
Parks, T., Smeesters, P. R., & Steer, A. C. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283511d27 · Cited by 181 · cited 1×
“Much of the GAS-associated mortality occurs in low income regions and populations [2].”
BackgroundSelf-citationCoiled-Coil Irregularities and Instabilities in Group A Streptococcus M1 Are Required for Virulence
McNamara, C., Zinkernagel, A. S., Macheboeuf, P., Cunningham, M. W., Nizet, V., & Ghosh, P. (2008) · Science · doi:10.1126/science.1154470 · Cited by 163 · cited 1×
“Most of the M protein sequence consists of heptad repeat motifs in which the first and fourth amino acids are typically hydrophobic, and are core stabilizing residues within the coiled coil [5].”
BackgroundBessen, D. E., & Fischetti, V. A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.4.1251 · Cited by 134
Self-citationDifferences between Belgian and Brazilian Group A Streptococcus Epidemiologic Landscape
Smeesters, P. R., Vergison, A., Campos, D., de Aguiar, E., Deyi, V. Y. M., & Melderen, L. V. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000010 · Cited by 115 · cited 1×
“The pattern classification, based on the content of emm gene forms and their chromosomal arrangement, was also recognized as a strong marker of preferred tissue sites of infection by GAS [13,29,30].”
BackgroundSelf-citationTissue Tropisms in Group a Streptococcal Infections
Bessen, D. E., & Lizano, S. (2010) · Future Microbiology · doi:10.2217/fmb.10.28 · Cited by 90 · cited 3×
“The pattern classification, based on the content of emm gene forms and their chromosomal arrangement, was also recognized as a strong marker of preferred tissue sites of infection by GAS [13,29,30].”
BackgroundMethodSelf-citationSmeesters, P. R., Mardulyn, P., Vergison, A., Leplae, R., & Melderen, L. V. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.08.037 · Cited by 75 · cited 5×
“The emm pattern of at least one isolate of each of the 168 emmtypes was experimentally determined following the PCR mapping methodology previously described [22] or deduced from previous publications [12,14].”
BackgroundMethodInfluentialSelf-citationSmeesters, P. R., McMillan, D. J., Sriprakash, K. S., & Georgousakis, M. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.133 · Cited by 63 · cited 4×
“Based on the data obtained in this study, and on information from published literature [4,9,10,13], we propose a new structural model with three representative M proteins (Fig.”
BackgroundMethodInfluentialSelf-citationGuerino, M. T., Postól, E., Demarchi, L. M. M. F., Martins, C., Mundel, L. R., Kalil, J. E., & Guilherme, L. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.113 · Cited by 45
Bauer, M. J., Georgousakis, M., Vu, T., Henningham, A., Hofmann, A., Rettel, M., Hafner, L. M., Sriprakash, K. S., & McMillan, D. J. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.115 · Cited by 31 · cited 3×
“One such vaccine candidate, J14, consists of 14 amino acid residues derived from CRR [17].”
BackgroundSelf-citation
Cited by
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
“A number of obstacles hinder the development of a GAS vaccine, including serotype diversity (528), antigenic variation (529), pronounced differences in the geographical distribution of serotypes (4), and, critically, the potential for GAS antigens to produce imGroup A Streptococcus Disease and Pathogenesis”
BackgroundSelf-citationPathogenesis, epidemiology and control of Group A Streptococcus infection
Brouwer, S., Rivera-Hernandez, T., Curren, B. F., Harbison-Price, N., De Oliveira, D. M. P., Jespersen, M. G., Davies, M. R., & Walker, M. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00865-7 · Cited by 374
Sanderson-Smith, M., De Oliveira, D. M. P., Guglielmini, J., McMillan, D. J., Vu, T., Holien, J. K., Henningham, A., Steer, A. C., Bessen, D. E., Dale, J. B., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu260 · Cited by 317
Self-citation
Metadata
- Authors
- McMillan, D. J., Drèze, P. A., Vu, T., Bessen, D. E., Guglielmini, J., Steer, A. C., Carapetis, J. R., Van Melderen, L., Sriprakash, K. S., & Smeesters, P. R.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 19
- Issue
- 5
- Pages
- E222-E229
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2108038478
- Cited by
- 183
- References
- 19
- FWCI
- 11.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.